tirzepatide westminster co ๐ (GLP-1) at Health Innovations ๐ Curious about new options in health and wellness support? Let's talk about Tirzepatideโa medication that has been gaining attention in the world of metabolic health Compounded Tirzepatide Weight Loss Program
Description
Schedule a consultation today
received research support from Novo Nordisk, Eli Lilly and Company, Boehringer, and Dexcom and consulting/advisory/honoraria fees from Abbott Diabetes, AstraZeneca, Bayer, Boehringer, Dexcom, Eli Lilly and Company, Novo Nordisk, and Medtronic
What is the beyond-use date assigned to this formulation
In a series of clinical trials (SURPASS 1-5) individuals with type 2 diabetes have shown reduction in both HbA1c (1.2 to 2.6%) and body weight (5.411.7 kg) (Nauck and D'Alessio 2022)
Among patients at high cardiovascular risk, the effect estimate was an HR of 0.88 (95% CI 0.73 to 1.07)
Obesity Physician An obesity physician leads the program
